Clinical Trial Update: Study Of The Repeat Dosing Of Ketoconazole On The Pharmacokinetics Of A Single Dose Of Pazopanib (GW786034) Eye Drops [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study assessing the effect of repeat dosing with ketoconazole on pazopanib eye drops in patients with macular degeneration.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• Ketoconazole (Ketoconazole)
• Pazopanib Eye Drops (GW786034) (pazopanib)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Macular Degeneration | Phase 1 | Status: COMPLETED